| Value | ₹410.0 Cr |
|---|
NSE filing, NSE: ARKADE. Summary written from the filing by ALFA Finder's alert engine.
Arkade Developers Ltd: key numbers
- Share price
- ₹107.07
- Market cap
- ₹1,988 Cr
- Revenue (annual)
- ₹816.4 Cr
- Net profit (annual)
- ₹5.38 Cr
- P/E (TTM)
- -78.3×Sector 34.4×
- Promoter holding
- 71.19%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arkade Developers Ltd
All →Arkade Developers Earnings Call Transcript: Key Takeaways
Arkade Developers maintains operational pace with strong collections despite moderated pre-sales, focusing on redevelopment projects in Mumbai's western suburbs.
Arkade Developers Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,447 Mn (-45.1% YoY), EBITDA ₹345 Mn (23.84% margin), PAT ₹248 Mn (-45.9%). H1 PAT ₹439 Mn. Collections up 22%; pre-sales weak; ₹19,000 Cr pipeline.
Arkade Developers Management Change
Arkade Developers appointed Maria S John as Interim Company Secretary and Compliance Officer from 01 Dec 2026. Sheetal Solani, currently Company Secretary, goes on maternity leave effective 30 Nov 2026.
Arkade Developers Results Update
Arkade Developers issued a press release on September 2026 quarter and half-year results. Q2 collections rose 22% to ₹183 crore; PAT reached ₹25 crore.
Arkade Developers Q2 FY27 Results: Net Profit ₹24.8 Cr, Down 45.9% YoY
Arkade Developers Ltd reported revenue from operations of ₹144.7 Cr (-45.1% YoY) and net profit of ₹24.8 Cr (-45.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹24.8 Cr · -45.9% YoY
Arkade Developers Board Meeting Date
Arkade Developers has scheduled a board meeting for October 28, 2026 to approve unaudited financial results. The trading window is closed from October 1, 2026 pending declaration.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.